BBB |
Blood–brain barrier |
CNS |
Central nervous system |
CSF |
Cerebrospinal fluid |
CXCL1 |
Chemokine (C-X-C motif) ligand 1 |
ECs |
Endothelial cells |
EGFR |
Epidermal growth factor receptor |
EPHA2 |
Ephrin type A receptor 2 |
EVs |
Extracellular vesicles |
GA-MSCs |
Glioma-associated (GA) mesenchymal stem cells (MSCs) |
GBM |
Glioblastoma multiforme |
GDEs |
GSC-derived exosomes |
GSCs |
Glioma stem-like cells |
HB-EGF |
Heparin-binding EGF-like growth factor |
hBMSCs |
human bone marrow MSCs |
HBMVECs |
human brain microvascular endothelial cells |
IL-6 |
Interleukin-6 |
IL-8 |
Interleukin-8 |
MCP3 |
Monocyte-chemotactic protein 3 |
miRNAs |
microRNAs |
MMPs |
Matrix metalloproteinases |
MSCs |
Mesenchymal stem cells |
MVs |
Microvesicles |
MVBs |
Multivesicular bodies |
NSCs |
Neural stem cells |
NRP1 |
Neuropilin |
ncRNAs |
noncoding RNAs |
PD-1 |
Programmed cell death-1 |
PD-L1 |
Programmed death-ligand 1 |
plxA1 |
PlexinA1 |
rGBM |
Recurrent GBM |
Sema |
Semaphorins |
Sema3A |
Semaphorin3A |
Sema3C |
Semapahorin3C |
STAT3 |
Signal transducer and activator of transcription 3 |
TAMs |
Tumor-associated macrophages |
TF |
Tissue factor |
TIMP-1 |
Tissue inhibitor of metalloproteinase-1 |
TIMP-2 |
Tissue inhibitor of metalloproteinase-2 |
TME |
Tumor microenvironment |
VEGF |
Vascular endothelial growth factor |
VEGFR2 |
Vascular endothelial growth factor receptor 2 |